CapsoVision receives FDA clearance for AI Highlights reading tool
CapsoVision announced FDA clearance for its AI Highlights tool on September 25, aimed at reducing physician review time for small bowel capsule endoscopy studies. The feature integrates into the CapsoCloud workflow, enhancing efficiency in GI disease detection.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed